Contribution to AML pathogenesis was assigned to splice variants of FLT3, aberrant splicing of BCL2 gene, linked with drug resistance, and overexpression of WT1 and E2F1 genes, which encode transcription factors taking part in AS regulation [170]. The gene discussed is FLT3; the disease is acute myeloid leukemia.